MedTrace Logo

Optimized Rehabilitation After Anterior Cruciate Ligament Before Returning to Sport

NCT05323474 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 432

Last updated 2026-04-24

No results posted yet for this study

Summary

Following reconstruction of the anterior cruciate ligament (ACL), a standardized rehabilitation protocol is carried out by a physiotherapist. In France, a well-established rehabilitation consensus guides the first phase of 3 months postoperatively and patient compliance is generally excellent. The next phase should allow a return to sport (RTS) following a continuum depending on the objectives of the sport's patient, starting with a return to running activities (RTR) and a preparatory phase for a RTS which may be authorized at 6 months post-op.

This multicentre randomized control trial aims to evaluate the effectiveness of an individualized and optimized rehabilitation program guided by monthly assessments carried out by physiotherapists from the 3rd to the 6th month postoperatively to reduce the risk of new ACL injuries (operated or healthy knee), compared to standard management.

Conditions

  • Ligament Knee Injury
  • Anterior Cruciate Ligament Rupture

Interventions

OTHER

Usual rehabilitation

Usual rehabilitation according to the practice of the "Haute Autorité de Santé" (HAS)

OTHER

Rehabilitation optimized

Rehabilitation optimized according to the study protocol

Sponsors & Collaborators

  • Ministry of Health, France

    collaborator OTHER_GOV

  • Centre Hospitalier Universitaire de Saint Etienne

    lead OTHER

Principal Investigators

  • Thomas NERI, MD · CHU DE SAINT-ETIENNE

  • Grégory MOREL, Physio · CHU DE SAINT-ETIENNE

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
25 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-14
Primary Completion
2028-03-31
Completion
2029-12-31

Countries

  • France
  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05323474 on ClinicalTrials.gov